These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 88577)

  • 21. An epidemic of Vibrio cholerae el tor Inaba resistant to several antibiotics with a conjugative group C plasmid coding for type II dihydrofolate reductase in Thailand.
    Tabtieng R; Wattanasri S; Echeverria P; Seriwatana J; Bodhidatta L; Chatkaeomorakot A; Rowe B
    Am J Trop Med Hyg; 1989 Dec; 41(6):680-6. PubMed ID: 2641646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Highly Resistant Cholera Outbreak Strain in Zimbabwe.
    Mashe T; Domman D; Tarupiwa A; Manangazira P; Phiri I; Masunda K; Chonzi P; Njamkepo E; Ramudzulu M; Mtapuri-Zinyowera S; Smith AM; Weill FX
    N Engl J Med; 2020 Aug; 383(7):687-689. PubMed ID: 32786196
    [No Abstract]   [Full Text] [Related]  

  • 23. Fluoroquinolone resistance in Vibrio cholerae O1: emergence of El Tor Inaba.
    Das S; Goyal R; Ramachandran VJ; Gupta S
    Ann Trop Paediatr; 2005 Sep; 25(3):211-2. PubMed ID: 16156987
    [No Abstract]   [Full Text] [Related]  

  • 24. Plasmid-borne multiple drug resistance in Vibrio cholerae serogroup O1, biotype El Tor: evidence for a point-source outbreak in Bangladesh.
    Glass RI; Huq MI; Lee JV; Threlfall EJ; Khan MR; Alim AR; Rowe B; Gross RJ
    J Infect Dis; 1983 Feb; 147(2):204-9. PubMed ID: 6827137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emergence of multiply antibiotic-resistant Vibrio cholerae in Bangladesh.
    Glass RI; Huq I; Alim AR; Yunus M
    J Infect Dis; 1980 Dec; 142(6):939-42. PubMed ID: 7462703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular Adaptations and Antibiotic Resistance in
    Narendrakumar L; Gupta SS; Johnson JB; Ramamurthy T; Thomas S
    Microb Drug Resist; 2019 Sep; 25(7):1012-1022. PubMed ID: 31021308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular Epidemiology and Antibiotic Susceptibility of Vibrio cholerae Associated with a Large Cholera Outbreak in Ghana in 2014.
    Eibach D; Herrera-León S; Gil H; Hogan B; Ehlkes L; Adjabeng M; Kreuels B; Nagel M; Opare D; Fobil JN; May J
    PLoS Negl Trop Dis; 2016 May; 10(5):e0004751. PubMed ID: 27232338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemics of severe cholera caused by El Tor Vibrio cholerae O1 Ogawa possessing the ctxB gene of the classical biotype in Orissa, India.
    Pal BB; Khuntia HK; Samal SK; Kar SK; Patnaik B
    Int J Infect Dis; 2010 May; 14(5):e384-9. PubMed ID: 19781971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transition of drug susceptibilities of Vibrio cholerae O1 in Lao People's Democratic Republic.
    Phantouamath B; Sithivong N; Sisavath L; Munnalath K; Khampheng C; Insisiengmay S; Higa N; Kakinohana S; Iwanaga M
    Southeast Asian J Trop Med Public Health; 2001 Mar; 32(1):95-9. PubMed ID: 11485103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antibiotic sensitivity of Vibrio cholerae 01, isolated in the Ukraine in 1994].
    Khaĭtovich AB; Ved'mina EA; Shenderovich VA; Vlasova IV
    Antibiot Khimioter; 1996 Jun; 41(6):25-8. PubMed ID: 9054324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Features of Vibrio cholerae 0:1 El Tor, Inaba serotype, isolated during the cholera epidemic in Cartagena (Colombia)].
    Salim Máttar V
    Enferm Infecc Microbiol Clin; 1992 Nov; 10(9):525-30. PubMed ID: 1489792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vibrio cholerae El Tor acquires plasmid-encoded resistance to gentamicin.
    Threlfall EJ; Rowe B
    Lancet; 1982 Jan; 1(8262):42. PubMed ID: 6119431
    [No Abstract]   [Full Text] [Related]  

  • 33. [Use of media with antibiotics for isolating resistant forms of the cholera vibrios].
    Libinzon AE; Bogdanova MI; Gol'dberg AM
    Antibiotiki; 1976 Feb; 21(2):141-4. PubMed ID: 776072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vibrio cholerae resistant to 2,4-diamino-6,7-diisopropylpteridine (O/129) isolated from patients with enteritis in Ceará, Brazil.
    Hofer E; Reis EM; Quintaes BR; Rodrigues DP; Feitosa IS; Angelo MR; Ribeiro LH
    J Health Popul Nutr; 2001 Mar; 19(1):39-42. PubMed ID: 11394182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clonal spread of multiply resistant strains of Vibrio cholerae O1 in Somalia.
    Maimone F; Coppo A; Pazzani C; Ismail SO; Guerra R; Procacci P; Rotigliano G; Omar KH
    J Infect Dis; 1986 Apr; 153(4):802-3. PubMed ID: 3950453
    [No Abstract]   [Full Text] [Related]  

  • 36. [Inc J plasmids identified for the first time in Vibrio cholerae El Tor].
    Korichi MN; Belhocine S; Rahal K
    Med Trop (Mars); 1997; 57(3):249-52. PubMed ID: 9513150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Bacteriological aspects of cholera in Chad (1991 and 1994 epidemics)].
    Massenet D; Djerane L; Gamougane K; Fournier JM
    Bull Soc Pathol Exot; 1995 Mar; 88(4):203-5. PubMed ID: 8640086
    [No Abstract]   [Full Text] [Related]  

  • 38. Vibrio cholerae O1 outbreak isolates in Mozambique and South Africa in 1998 are multiple-drug resistant, contain the SXT element and the aadA2 gene located on class 1 integrons.
    Dalsgaard A; Forslund A; Sandvang D; Arntzen L; Keddy K
    J Antimicrob Chemother; 2001 Dec; 48(6):827-38. PubMed ID: 11733467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Characteristics of the cholera epidemic of 1998 in Ecuador during El Niño].
    Gabastou JM; Pesantes C; Escalante S; Narváez Y; Vela E; García L; Zabala D; Yadon ZE
    Rev Panam Salud Publica; 2002 Sep; 12(3):157-64. PubMed ID: 12396633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro anti-Vibrio cholerae activity of essential oil from Lepechinia caulescens.
    Acevedo JG; López JL; Cortés AM; Bores AM; Cortés GM; Castro IP
    Fitoterapia; 2005 Jan; 76(1):104-7. PubMed ID: 15664471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.